Terms: = Thyroid cancer AND PIK3CA, MGC142161, 5290, ENSG00000121879, P42336, MGC142163, p110-alpha, PI3K AND Diagnosis
70 results:
1. The emerging role and clinical significance of circRNAs in papillary thyroid cancer.
Ma J; Xu J; Zhang X; Quan J
Front Endocrinol (Lausanne); 2024; 15():1351776. PubMed ID: 38544689
[TBL] [Abstract] [Full Text] [Related]
2. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
Zhang X; Meng X; Wang P; Luan C; Wang H
Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
[TBL] [Abstract] [Full Text] [Related]
3. Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with
Oh Y; Park JH; Djunadi TA; Shah Z; Chung LI; Chae YK
Front Endocrinol (Lausanne); 2024; 15():1304188. PubMed ID: 38356955
[TBL] [Abstract] [Full Text] [Related]
4. Bioinformatics analysis identifies coagulation factor II receptor as a potential biomarker in stomach adenocarcinoma.
Wu X; Wang S; Wang C; Wu C; Zhao Z
Sci Rep; 2024 Jan; 14(1):2468. PubMed ID: 38291086
[TBL] [Abstract] [Full Text] [Related]
5. EPYC functions as a novel prognostic biomarker for pancreatic cancer.
Yang Z; Li H; Hao J; Mei H; Qiu M; Wang H; Gao M
Sci Rep; 2024 Jan; 14(1):719. PubMed ID: 38184732
[TBL] [Abstract] [Full Text] [Related]
6. IRS1 promotes thyroid cancer metastasis through EMT and pi3k/AKT pathways.
Yu F; Huang D; Kuang Y; Dong J; Han Q; Zhou J; Teng X
Clin Endocrinol (Oxf); 2024 Mar; 100(3):284-293. PubMed ID: 38172081
[TBL] [Abstract] [Full Text] [Related]
7. TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary thyroid Carcinoma in a Colombian Cohort.
Cruz-Romero SD; González S; Juez JY; Becerra DS; Baldión AM; Hakim JA; González-Devia D; Perdomo S; Rodríguez-Urrego PA
Adv Ther; 2024 Feb; 41(2):792-805. PubMed ID: 38170436
[TBL] [Abstract] [Full Text] [Related]
8. HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via pi3k/AKT signaling pathway in human anaplastic thyroid carcinoma.
Zhong Y; Yu F; Yang L; Wang Y; Liu L; Jia C; Cai H; Yang J; Sheng S; Lv Z; Weng L; Wu B; Zhang X
J Transl Med; 2023 Nov; 21(1):817. PubMed ID: 37974228
[TBL] [Abstract] [Full Text] [Related]
9. Significance of LINC02082 and LOC105369812 in differentiating papillary thyroid cancer from benign nodules.
Xu J; Liu W; Li R; Wang Y
Medicine (Baltimore); 2023 Nov; 102(44):e35542. PubMed ID: 37932992
[TBL] [Abstract] [Full Text] [Related]
10. Circular RNAs: characteristics, functions, mechanisms, and potential applications in thyroid cancer.
Wu M; Yuan H; Zou W; Xu S; Liu S; Gao Q; Guo Q; Han Y; An X
Clin Transl Oncol; 2024 Apr; 26(4):808-824. PubMed ID: 37864677
[TBL] [Abstract] [Full Text] [Related]
11. AKT-independent signaling in pik3ca-mutant thyroid cancer mediates resistance to dual SRC and MEK1/2 inhibition.
Rose MM; Nassar KW; Sharma V; Schweppe RE
Med Oncol; 2023 Sep; 40(10):299. PubMed ID: 37713162
[TBL] [Abstract] [Full Text] [Related]
12. The roles and mechanisms of circular RNAs related to mTOR in cancers.
Cao C; Wang Y; Wu X; Li Z; Guo J; Sun W
J Clin Lab Anal; 2022 Dec; 36(12):e24783. PubMed ID: 36426933
[TBL] [Abstract] [Full Text] [Related]
13. EIF1AX mutation in thyroid tumors: a retrospective analysis of cytology, histopathology and co-mutation profiles.
Elsherbini N; Kim DH; Payne RJ; Hudson T; Forest VI; Hier MP; Payne AE; Pusztaszeri MP
J Otolaryngol Head Neck Surg; 2022 Nov; 51(1):43. PubMed ID: 36371345
[TBL] [Abstract] [Full Text] [Related]
14. Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability.
Hong S; Xie Y; Cheng Z; Li J; He W; Guo Z; Zhang Q; Peng S; He M; Yu S; Xu L; Liu R; Xu T; Zhang Y; Li Y; Wang J; Lv W; Yu J; Xiao H
Oncogene; 2022 Nov; 41(47):5121-5132. PubMed ID: 36253446
[TBL] [Abstract] [Full Text] [Related]
15.
Xu M; Wen J; Xu Q; Li H; Lin B; Bhandari A; Qu J
Curr Cancer Drug Targets; 2024; 24(2):220-229. PubMed ID: 36089788
[TBL] [Abstract] [Full Text] [Related]
16. Melanotic medullary thyroid carcinoma: A case report with review of the literature.
Brzezinska KA; Bhardwaj S; Teng MS; Si Q; Sun J; Westra WH; Zakowski MF; Szporn AH
Diagn Cytopathol; 2023 Jan; 51(1):E14-E20. PubMed ID: 36056712
[TBL] [Abstract] [Full Text] [Related]
17. Recognition of Key Genes in Human Anaplastic thyroid cancer via the Weighing Gene Coexpression Network.
Gong Y; Xu F; Deng L; Peng L
Biomed Res Int; 2022; 2022():2244228. PubMed ID: 35782055
[TBL] [Abstract] [Full Text] [Related]
18. Rab22a Promotes Epithelial-Mesenchymal Transition in Papillary thyroid Carcinoma by Activating pi3k/AKT/mTOR Signaling Pathway.
Luo X; Wang J; Lu J; Wang X; Miao Y; Li Q; Li X; Wang L
Biomed Res Int; 2022; 2022():1874550. PubMed ID: 35757470
[TBL] [Abstract] [Full Text] [Related]
19. Single-Cell Transcriptome Analysis Reveals Inter-Tumor Heterogeneity in Bilateral Papillary thyroid Carcinoma.
Wang T; Shi J; Li L; Zhou X; Zhang H; Zhang X; Wang Y; Liu L; Sheng L
Front Immunol; 2022; 13():840811. PubMed ID: 35515000
[TBL] [Abstract] [Full Text] [Related]
20. The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findings.
Regazzo D; Bertazza L; Galletta E; Barollo S; Mondin A; Zovato S; Iacobone M; Zilio E; Scaroni C; Radu CM; di Benedetto G; Mian C; Lefkimmiatis K; Occhi G
Endocr Relat Cancer; 2022 Apr; 29(5):273-284. PubMed ID: 35298396
[TBL] [Abstract] [Full Text] [Related]
[Next]